Medical Director, Digestive Health Center
Northwestern University Feinberg School of Medicine
Internationally recognized expert on the treatment of inflammatory bowel disease (IBD), former chair of the FDA Gastrointestinal Drugs Advisory Committee and advisor on the development of multiple leading IBD drugs
Dr. Hanauer is a board certified internist and gastroenterologist, and is the Clifford Joseph Barborka Professor of Medicine and Medical Director of the Digestive Health Center at Northwestern University’s Feinberg School of Medicine. Dr. Hanauer is a Fellow and past President of the American College of Gastroenterology (ACG) and the former Chair of the American Gastroenterological Association’s Inflammation, Immunology, and IBD Section. He is also a prior member of the Gastroenterology Specialty Board of the American Board of Internal Medicine and is a member and former-Chairman of the International Organization for Inflammatory Bowel Disease. Dr. Hanauer has expertise in designing and leading clinical studies for IBD related therapies and has acted as a clinical investigator and/or advisor to pharmaceutical companies in the development of many of the leading IBD therapies, including: Uceris®, Asacol HD®, Remicade®,Humira®, and Entyvio®.
Dr. Hanauer has authored over 425 peer-reviewed journal articles and numerous books and book chapters, abstracts, monographs, and editorials.
Dr. Hanauer received his medical degree from the University of Illinois Chicago, and he completed his residency in internal medicine and a fellowship in gastroenterology at the University of Chicago in 1982. Dr. Hanauer is the Medical Director of Digestive Health Center at Northwestern where he continues to treat IBD patients and conducts research into new therapies.
Saturday, April 6
1:10 PM – 1:50 PM